All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the Lymphoma Coalition

The Lymphoma Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

Satellite Symposium | How to treat early relapse in a patient with FL

The virtual Lymphoma Hub Satellite Symposium, at the 16th International Conference on Malignant Lymphoma (16-ICML), saw a panel of international experts come together to discuss the sequencing of therapies in high-risk relapsed/refractory lymphoma and chronic lymphocytic leukemia. Professor Loretta J. Nastoupil, MD Anderson Cancer Center, Houston, US, discusses how to treat early relapse in a patient with follicular lymphoma (FL).

Lymphoma Hub Satellite Symposium: Watch here!

Welcome to the Lymphoma Hub Satellite Symposium.

Please take a moment to complete the survey and answer the following questions to help us gauge your current understanding of the sequencing of therapy for patients with early relapsing FL.

Nastoupil begins by outlining a clinical case and the benefits of utilizing PET scans to exclude transformation as the driver of poor outcomes. The presentation then reviews therapeutic options and the data that inform treatment selection, including data from the GADOLIN, AUGMENT, GALEN, and SWOG trials. Finally, Nastoupil describes how she would approach this case, utilizing available clinical trials that employ novel agents, such as tazemetostat and tafasitamab, and she offers insight for those that practice in a different setting.

Satellite Symposium | How to treat early relapse in a patient with FL

If you would like to download the slides from Loretta Nastoupil's presentation, click below

Download here

Share: